10:03 AM EST - Odyssey Group International Inc : Announces its continued commitment to the newly formed entity, Odyssey NeuroPharma, with the expansion of its executive team. Joining the executive team at Odyssey NeuroPharma to advance Odyssey’s concussion treatment, and Niemann-Pick treatment, is Erik Emerson as Chief Commercial Officer and Greg Gironda as Chief Operating Officer. Mr. Emerson and Mr. Gironda have over 50 years of collective pharmaceutical experience in commercializing innovative pharmaceutical compounds with leading pharmaceutical companies. Odyssey Group International Inc
shares O.ODYY are trading -$0.02 at $0.22.
